Clinical Trials Directory

Trials / Completed

CompletedNCT05237583

Prehabilitation for Patients Awaiting Liver Transplantation

Does a Multimodal Prehabilitation Program Improve Markers of Frailty in Patients With Cirrhosis Undergoing Liver Transplantation? A Feasibility Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study will assess the feasibility, safety and effectiveness of a structured prehabilitation program combining exercise training, nutritional optimization and psychological support for patients with cirrhosis awaiting liver transplantation.

Detailed description

Due to their chronic liver disease, patients with cirrhosis awaiting liver transplantation develop low muscle mass, poor nutritional status and decreased reserves putting them at high risk of postoperative complications, prolonged hospital stay, and failed discharge home after liver transplantation. Prehabilitation aims to optimize a patient before they undergo a major surgery. These programs combine exercise training, with nutritional optimization and psychological support. Together, these contribute to improve their muscle mass, tolerance to exercise, and nutritional status. The current study will assess whether an individualized and structured prehabilitation program combining supervised exercise training, nutritional optimization and psychological support will benefit patients with cirrhosis awaiting liver transplantation.

Conditions

Interventions

TypeNameDescription
BEHAVIORALPrehabilitationAll participants will be offered a multimodal prehabilitation program. This program will include an individualized and supervised aerobic and resistance exercise training program, nutritional optimization, and psychological support. The program will last 6 months or until liver transplantation, whichever comes first.

Timeline

Start date
2022-02-23
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2022-02-14
Last updated
2026-04-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05237583. Inclusion in this directory is not an endorsement.